期刊文献+

首批异替勃龙国家对照品的标定研究

Standardization of the First Batch National Standard of Isobolone
下载PDF
导出
摘要 目的制备并标定首批异替勃龙国家对照品,以有效控制替勃龙及其制剂产品质量。方法应用红外光谱、质谱、核磁共振谱对异替勃龙进行结构确证,采用反相高效液相色谱(HPLC)法测定待标品纯度,采用质量平衡法对待标品进行赋值,并对待标品的均一性和稳定性进行考察。结果异替勃龙待标品经标定,以C_(21)H_(28)O_(2)计,含量为99.6%;均一性考察符合要求,25℃±2℃、RH 75%±5%条件,40℃±2℃、RH 75%±5%条件,光照4500 lx±500 lx条件下放置10 d,纯度略有下降。结论本批待标品确认为异替勃龙,可作为第一批异替勃龙国家对照品,以供异替勃龙HPLC法鉴别和含量测定用,以C_(21)H_(28)O_(2)计,本批待标品含量为99.6%。 Objective To prepare and calibrate thefirst batch national standard(NS)of isobolone in order to assure the quality of tibolone and its preparation.Methods The structure of isobolone was confirmed by infrared spectroscopy,mass spectrometry,and nuclear magnetic resonance spectroscopy.RP-HPLC method was used to determine the purity,the mass balance method was used to assign a value to the candidate preparation.Thermal stability and uniformity test for the candidate preparation were carried out.Results The content of the NS candidate of isobolone is 99.6%as C_(21)H_(28)O_(2).The uniformity inspection meets the requirements.The purity decreased slightly placed under 25℃±2℃,RH 75%±5%conditions,40℃±2℃,RH 75%±5%conditions,light 4500 lx±500 lx conditions for 10 days.Conclusions The candidate preparation was confirmed to be the isobolone to serve as thefirst batch NS isobolone which can be used for HPLC identification,content determination.The content of the NS candidate of isobolone is 99.6%as C_(21)H_(28)O_(2).
作者 孙悦 张伟 胡馨月 张慧 梁成罡 SUN Yue;ZHANG Wei;HU Xinyue;ZHANG Hui;LIANG Chenggang(Division of Hormone,National Institutes for Food and Drug Control,NMPA Key Laboratory for Quality Research and Evaluation of Chemical Drugs,Beijing 102629,China)
出处 《中国医药指南》 2024年第1期37-41,共5页 Guide of China Medicine
关键词 异替勃龙 替勃龙 国家对照品 含量 质量平衡法 Isobolone Tibolone National standard Content Mass balance method
  • 相关文献

参考文献3

二级参考文献33

  • 1国家食品药品监督管理总局.药品注册管理办法[EB/OL].http://www.sda.gov.cn/WS01/CL0053/24529.html,2007-10-01.
  • 2张哲峰.对药品注册中对照品(标准品)有关技术要求的几点思考[EB/OL].[2005-05-22].http://www.cde.org.cn/dzkw.do?method=largePage&id=1418.CDE.
  • 3ICH. Harmonized tripartite guideline Q6A: Specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances [ EB/OL]. (1999 - 10 - 16) [ 2015 - 09 - 05 ]. http://www, ich. org/fileadmin/ Public _ Web _ Site/ICH _ Products/Guidelines/Quality/Q6A! StelM-/Q6AstelM. pdf.
  • 4WHO. General guidelines for the establishment, maintenance and distribution of chemical reference substances [ EB/OL ]. WHO technical report series, No. 943, 2007 (2015 - 09 - 05 ). http://www, apps. who. int/prequal/info _ general/documents/ TRS943/WHO_TRS_943-Annex3. pdf? ua = 1.
  • 5ICH. Harmonized tripartite guideline M4Q ( R1 ) : The common technical document for the registration of pharmaceuticals for hu- man use: quality ~EB/OL]. (2002 -09-12) [2015 -09- 05 ], http://www, ich. org/fileadmin/Public_Web_Site/ICH_ Products/CTD/M4_Rl_Qualitv/M40_RI_. Ddf.
  • 6国家食品药品监督管理总局.关于按CTD格式撰写化学药品注册申报资料有关事项的通知[EB/OL].(2010-09-25)[2015-09-05].http://www.sda.gov.cn/W~l/CL0844/54391.html.
  • 7WHO. Guidelines on submission of documentation for a multi- source (generic) finished pharmaceutical product for the WHO Prequalification of Medicines Programme: quality part ~ EB/ OL]. 2012(2015 -09 -05). WHO technical report series, No. 943.
  • 8Health Canada. Pharmaceutical sciences-questions and answers [EB/OL1. (2007-05-23) [2015 -09 -05]. http://www. hc-sc, gc. ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/ ps_qa_sp_qr-eng, pdf.
  • 9EMA. Guideline on the chemistry of new active substances [ EB/ OL1. (2003-12-17) [2015 -09-161.http://www. ema. europa, eu/docs/en_GB/document_library/Scientific_guideline/ 2009/09/WC500002815. pdf.
  • 10ICH. Harmonized tripartite guideline Q7 : Good manufacturing practice guide for active pharmaceutical ingredients [ EB/OL ]. (2000- 11 - 10) [2015 -09 -05]. http://www, ich. org/ fileadmin/Public_Web_ Site/ICH Products/Guidelines/Quality/ Q7/Step4/Q7_Guideline. pdf.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部